IL259561B - Methods of predicting progression of barrett's esophagus - Google Patents
Methods of predicting progression of barrett's esophagusInfo
- Publication number
- IL259561B IL259561B IL259561A IL25956118A IL259561B IL 259561 B IL259561 B IL 259561B IL 259561 A IL259561 A IL 259561A IL 25956118 A IL25956118 A IL 25956118A IL 259561 B IL259561 B IL 259561B
- Authority
- IL
- Israel
- Prior art keywords
- barrett
- esophagus
- predicting
- progression
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562260010P | 2015-11-25 | 2015-11-25 | |
| PCT/US2016/063482 WO2017091658A1 (en) | 2015-11-25 | 2016-11-23 | Methods of predicting progression of barrett's esophagus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL259561A IL259561A (en) | 2018-07-31 |
| IL259561B true IL259561B (en) | 2020-06-30 |
Family
ID=58763606
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL259561A IL259561B (en) | 2015-11-25 | 2018-05-23 | Methods of predicting progression of barrett's esophagus |
| IL275126A IL275126B (en) | 2015-11-25 | 2020-06-04 | Methods for predicting the progression of Barrett's esophagus |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL275126A IL275126B (en) | 2015-11-25 | 2020-06-04 | Methods for predicting the progression of Barrett's esophagus |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10962544B2 (de) |
| EP (4) | EP3380840B1 (de) |
| AU (2) | AU2016359685B2 (de) |
| CA (1) | CA3006356C (de) |
| ES (3) | ES2831754T3 (de) |
| IL (2) | IL259561B (de) |
| WO (1) | WO2017091658A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2739623T3 (es) | 2011-03-17 | 2020-02-03 | Cernostics Inc | Sistemas y composiciones para diagnosticar el esófago de Barrett y métodos para usarlos |
| EP3380840B1 (de) | 2015-11-25 | 2020-08-19 | Cernostics, Inc. | Verfahren zur vorhersage der progression von barrett-ösophagus |
| US20260057961A1 (en) * | 2022-08-16 | 2026-02-26 | The Regents Of The University Of California | Chromosome 9p24 loss and gain predicts resistance and benefit of immune checkpoint inhibitors |
Family Cites Families (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1791192A (en) | 1991-04-05 | 1992-11-02 | Pattern Recognition | Direct data base analysis, forecasting and diagnosis method |
| US6025128A (en) | 1994-09-29 | 2000-02-15 | The University Of Tulsa | Prediction of prostate cancer progression by analysis of selected predictive parameters |
| ATE496288T1 (de) | 1995-10-11 | 2011-02-15 | Luminex Corp | Gleichzeitige mehrfachanalyse klinischer proben |
| EP0929694A4 (de) | 1996-03-15 | 2002-05-02 | Penn State Res Found | Nachweis von extrazellulärer tumor-assoziierter nukleinsäuren im blutplasma oder -serum mittels eines nukleinsäure-amplifizierungsverfahren |
| US6103479A (en) | 1996-05-30 | 2000-08-15 | Cellomics, Inc. | Miniaturized cell array methods and apparatus for cell-based screening |
| US5989835A (en) | 1997-02-27 | 1999-11-23 | Cellomics, Inc. | System for cell-based screening |
| US6059724A (en) | 1997-02-14 | 2000-05-09 | Biosignal, Inc. | System for predicting future health |
| US6759206B1 (en) | 1997-02-27 | 2004-07-06 | Cellomics, Inc. | System for cell-based screening |
| US7853411B2 (en) | 1997-02-27 | 2010-12-14 | Cellomics, Inc. | System for cell-based screening |
| US6416959B1 (en) | 1997-02-27 | 2002-07-09 | Kenneth Giuliano | System for cell-based screening |
| DE69839501D1 (de) | 1997-02-27 | 2008-06-26 | Cellomics Inc | System für Screening biologischer Zellen |
| US7117098B1 (en) | 1997-02-27 | 2006-10-03 | Cellomics, Inc. | Machine-readable storage medium for analyzing distribution of macromolecules between the cell membrane and the cell cytoplasm |
| US6727071B1 (en) | 1997-02-27 | 2004-04-27 | Cellomics, Inc. | System for cell-based screening |
| US6259807B1 (en) | 1997-05-14 | 2001-07-10 | Applied Imaging Corp. | Identification of objects of interest using multiple illumination schemes and finding overlap of features in corresponding multiple images |
| US6324479B1 (en) | 1998-05-08 | 2001-11-27 | Rosetta Impharmatics, Inc. | Methods of determining protein activity levels using gene expression profiles |
| US6218122B1 (en) | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
| CA2348132C (en) | 1998-10-30 | 2003-08-12 | Cellomics, Inc. | A system for cell-based screening |
| WO2000070528A2 (en) | 1999-05-14 | 2000-11-23 | Cytokinetics, Inc. | Method and apparatus for predictive cellular bioinformatics |
| US20030228565A1 (en) | 2000-04-26 | 2003-12-11 | Cytokinetics, Inc. | Method and apparatus for predictive cellular bioinformatics |
| US6986993B1 (en) | 1999-08-05 | 2006-01-17 | Cellomics, Inc. | System for cell-based screening |
| EP1283904A2 (de) | 1999-11-03 | 2003-02-19 | Oncotech, Inc. | Diagnose von krebs mit zellsortierung und genexpressionsprofilen |
| AU2001229637A1 (en) | 2000-01-21 | 2001-07-31 | Thomas Jefferson University | Nipple aspirate fluid specific microarrays |
| US6763307B2 (en) | 2000-03-06 | 2004-07-13 | Bioseek, Inc. | Patient classification |
| EP1274861B1 (de) | 2000-03-27 | 2009-12-23 | Thomas Jefferson University | Zusammensetzungen und methoden zur identifizierung von krebszellen |
| WO2001074405A1 (en) | 2000-03-31 | 2001-10-11 | Gene Logic, Inc. | Gene expression profiles in esophageal tissue |
| JP2004502434A (ja) | 2000-07-04 | 2004-01-29 | バイオイメージ エイ／エス | 細胞成分間の相互作用に関する量的情報の抽出方法 |
| AU2001294872A1 (en) | 2000-09-28 | 2002-04-08 | Cellomics, Inc. | Methods and reagents for live-cell gene expression quantification |
| US20060148732A1 (en) | 2000-11-17 | 2006-07-06 | Gutterman Jordan U | Inhibition of NF-kappaB by triterpene compositions |
| WO2002077903A2 (en) | 2001-03-26 | 2002-10-03 | Cellomics, Inc. | Methods for determining the organization of a cellular component of interest |
| US7219016B2 (en) | 2001-04-20 | 2007-05-15 | Yale University | Systems and methods for automated analysis of cells and tissues |
| US20040043436A1 (en) | 2001-09-21 | 2004-03-04 | Antonia Vlahou | Biomarkers of transitional cell carcinoma of the bladder |
| US7274809B2 (en) | 2002-08-29 | 2007-09-25 | Perceptronix Medical, Inc. And British Columbia Cancer Agency | Computerized methods and systems related to the detection of malignancy-associated changes (MAC) to detect cancer |
| US7801361B2 (en) | 2002-10-15 | 2010-09-21 | Definiens Ag | Analyzing pixel data using image, thematic and object layers of a computer-implemented network structure |
| EP1565570A4 (de) | 2002-11-12 | 2005-12-28 | Becton Dickinson Co | Sepsis- oder sirs-diagnose mittels biomarkerprofilen |
| CA2516795C (en) | 2003-02-27 | 2013-01-15 | Immunivest Corporation | Circulating tumor cells (ctc's): early assessment of time to progression,_survival and response to therapy in metastatic cancer patients |
| WO2004094992A2 (en) | 2003-04-23 | 2004-11-04 | Bioseek, Inc. | Methods for analysis of biological dataset profiles |
| US7461048B2 (en) | 2003-07-21 | 2008-12-02 | Aureon Laboratories, Inc. | Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition |
| US7505948B2 (en) | 2003-11-18 | 2009-03-17 | Aureon Laboratories, Inc. | Support vector regression for censored data |
| US20050136509A1 (en) | 2003-09-10 | 2005-06-23 | Bioimagene, Inc. | Method and system for quantitatively analyzing biological samples |
| US7760927B2 (en) | 2003-09-10 | 2010-07-20 | Bioimagene, Inc. | Method and system for digital image based tissue independent simultaneous nucleus cytoplasm and membrane quantitation |
| WO2005050563A2 (en) | 2003-11-17 | 2005-06-02 | Aureon Biosciences Corporation | Pathological tissue mapping |
| WO2005091203A2 (en) | 2004-03-12 | 2005-09-29 | Aureon Laboratories, Inc. | Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition |
| WO2006020627A1 (en) | 2004-08-11 | 2006-02-23 | Aureon Laboratories, Inc. | Systems and methods for automated diagnosis and grading of tissue images |
| CA2580795A1 (en) | 2004-09-22 | 2006-04-06 | Tripath Imaging, Inc. | Methods and compositions for evaluating breast cancer prognosis |
| EP1645881A1 (de) | 2004-10-05 | 2006-04-12 | DKFZ Deutsches Krebsforschungszentrum | Screening-Verfahren zum Auffinden und Charakterisieren von Protein-Protein-Wechselwirkungen in vivo durch "fluorescence cross correlation spectroscopy" |
| US20060159325A1 (en) | 2005-01-18 | 2006-07-20 | Trestle Corporation | System and method for review in studies including toxicity and risk assessment studies |
| US7537894B2 (en) | 2005-03-02 | 2009-05-26 | The University Of Chicago | Methods and kits for monitoring Barrett's metaplasia |
| US20070019854A1 (en) | 2005-05-10 | 2007-01-25 | Bioimagene, Inc. | Method and system for automated digital image analysis of prostrate neoplasms using morphologic patterns |
| US7599893B2 (en) | 2005-10-13 | 2009-10-06 | Aureon Laboratories, Inc. | Methods and systems for feature selection in machine learning based on feature contribution and model fitness |
| GB0521521D0 (en) | 2005-10-21 | 2005-11-30 | Medical Res Council | Diagnostic methods and kits |
| GB2433986A (en) | 2006-01-09 | 2007-07-11 | Cytokinetics Inc | Granularity analysis in cellular phenotypes |
| US20090170091A1 (en) | 2006-01-17 | 2009-07-02 | Kenneth Giuliano | Method For Predicting Biological Systems Responses |
| JP2009524438A (ja) | 2006-01-27 | 2009-07-02 | トライパス イメージング インコーポレイテッド | 卵巣癌を有する可能性の高い患者を同定するための方法およびそのための組成物 |
| WO2007089911A2 (en) | 2006-01-30 | 2007-08-09 | The Scripps Research Institute | Methods for detection of circulating tumor cells and methods of diagnosis of cancer in a mammalian subject |
| US8367351B2 (en) | 2006-05-05 | 2013-02-05 | Historx, Inc. | Methods for determining signal transduction activity in tumors |
| CN101484806A (zh) | 2006-05-17 | 2009-07-15 | 协乐民公司 | 一种对组织进行自动分析的方法 |
| CA2657691A1 (en) | 2006-06-19 | 2007-12-27 | Vanderbilt University | Methods and compositions for diagnostic and therapeutic targeting of cox-2 |
| US7706591B2 (en) | 2006-07-13 | 2010-04-27 | Cellomics, Inc. | Neuronal profiling |
| US7811778B2 (en) | 2006-09-06 | 2010-10-12 | Vanderbilt University | Methods of screening for gastrointestinal cancer |
| EP2095119A2 (de) | 2006-11-10 | 2009-09-02 | Cellumen, Inc. | Biosensoren für protein-protein-interaktion und verfahren zu ihrer verwendung |
| WO2009105533A2 (en) | 2008-02-19 | 2009-08-27 | The Johns Hopkins University | Methods for predicting esophageal adenocarcinoma (eac) |
| WO2010121266A1 (en) | 2009-04-18 | 2010-10-21 | The Regents Of The University Of Michigan | Targeted detection of dysplasia in barrett's esophagus with a novel fluorescence-labeled polypeptide |
| EP2524059A4 (de) | 2010-01-13 | 2013-11-20 | Caris Life Sciences Luxembourg Holdings | Detektion von gastrointestinalen erkrankungen |
| KR20130043104A (ko) | 2010-04-06 | 2013-04-29 | 카리스 라이프 사이언스 룩셈부르크 홀딩스 | 질병용 순환 생물학적 지표들 |
| WO2012024543A1 (en) * | 2010-08-18 | 2012-02-23 | Caris Life Sciences Luxembourg Holdings | Circulating biomarkers for disease |
| ES2739623T3 (es) * | 2011-03-17 | 2020-02-03 | Cernostics Inc | Sistemas y composiciones para diagnosticar el esófago de Barrett y métodos para usarlos |
| US20130078632A1 (en) | 2011-09-23 | 2013-03-28 | Academisch Medisch Centrum | Materials and methods for prognosis of progression of barrett's esophagus |
| EP3380840B1 (de) | 2015-11-25 | 2020-08-19 | Cernostics, Inc. | Verfahren zur vorhersage der progression von barrett-ösophagus |
-
2016
- 2016-11-23 EP EP16869219.2A patent/EP3380840B1/de active Active
- 2016-11-23 EP EP25202993.9A patent/EP4679093A3/de active Pending
- 2016-11-23 EP EP20184506.2A patent/EP3786640B1/de active Active
- 2016-11-23 ES ES16869219T patent/ES2831754T3/es active Active
- 2016-11-23 CA CA3006356A patent/CA3006356C/en active Active
- 2016-11-23 ES ES20184506T patent/ES2931924T3/es active Active
- 2016-11-23 EP EP22184193.5A patent/EP4152001B1/de active Active
- 2016-11-23 ES ES22184193T patent/ES3056977T3/es active Active
- 2016-11-23 US US15/778,403 patent/US10962544B2/en active Active
- 2016-11-23 WO PCT/US2016/063482 patent/WO2017091658A1/en not_active Ceased
- 2016-11-23 AU AU2016359685A patent/AU2016359685B2/en active Active
-
2018
- 2018-05-23 IL IL259561A patent/IL259561B/en active IP Right Grant
-
2020
- 2020-06-04 IL IL275126A patent/IL275126B/en active IP Right Grant
-
2021
- 2021-03-12 US US17/200,260 patent/US12442819B2/en active Active
-
2023
- 2023-02-06 AU AU2023200590A patent/AU2023200590B2/en active Active
-
2025
- 2025-09-18 US US19/332,502 patent/US20260079160A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023200590A1 (en) | 2023-03-09 |
| IL275126B (en) | 2021-05-31 |
| AU2016359685B2 (en) | 2022-12-22 |
| US20220034894A1 (en) | 2022-02-03 |
| EP4679093A2 (de) | 2026-01-14 |
| CA3006356C (en) | 2024-07-02 |
| CA3006356A1 (en) | 2017-06-01 |
| EP3786640B1 (de) | 2022-08-24 |
| US10962544B2 (en) | 2021-03-30 |
| EP4152001B1 (de) | 2025-10-22 |
| EP4152001A1 (de) | 2023-03-22 |
| WO2017091658A1 (en) | 2017-06-01 |
| EP3786640A1 (de) | 2021-03-03 |
| US12442819B2 (en) | 2025-10-14 |
| IL259561A (en) | 2018-07-31 |
| AU2023200590B2 (en) | 2025-10-02 |
| AU2016359685A1 (en) | 2018-06-14 |
| EP3380840A4 (de) | 2019-06-26 |
| EP3380840A1 (de) | 2018-10-03 |
| EP3380840B1 (de) | 2020-08-19 |
| US20180348226A1 (en) | 2018-12-06 |
| ES3056977T3 (en) | 2026-02-25 |
| IL275126A (en) | 2020-07-30 |
| ES2831754T3 (es) | 2021-06-09 |
| ES2931924T3 (es) | 2023-01-04 |
| US20260079160A1 (en) | 2026-03-19 |
| EP4679093A3 (de) | 2026-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL263955B (en) | Registration maps using intra-cardiac signals | |
| EP3464313A4 (de) | 5'-cyclo-phosphonatmodifizierte nukleotide | |
| EP3430731A4 (de) | Iugw-architektur | |
| PT3368534T (pt) | Ditosilato de valbenazina e polimorfos do mesmo | |
| IL264143B (en) | Processes for preparing olaparib | |
| CU20160125A7 (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| EP3286549A4 (de) | Biosensor | |
| EP3428388A4 (de) | Tunnelbohrmaschine | |
| DK3504506T3 (da) | Mål | |
| EP3156789C0 (de) | Biosensor | |
| KR20180084876A (ko) | 내플라즈마성 부재 | |
| DK3262182T3 (da) | Modificeret creatinase | |
| DE112017003628A5 (de) | Fortbewegungshilfe | |
| EP3347334A4 (de) | Dehydrohalogenierung von fluorchlorkohlenwasserstoffen | |
| HUE042606T2 (hu) | Eljárás apolipoprotein kimutatására | |
| EP3535617A4 (de) | Sehhilfe | |
| EP3387414A4 (de) | Biosensor | |
| EP3325857A4 (de) | Abstreifring | |
| MA45305A (fr) | Suspension améliorée | |
| EP3684343A4 (de) | Verbesserte suprapartikel | |
| EP3371575A4 (de) | Biosensor | |
| EP3449805A4 (de) | Resektoskop | |
| EP3344280A4 (de) | Bildung von knochen | |
| IL275126B (en) | Methods for predicting the progression of Barrett's esophagus | |
| EP3467158A4 (de) | Tiegel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |